Modeling proportional hazards models. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Fruit Lower Extremity

Organisms1

Diseases66

Breast Neoplasms Cardiovascular Diseases Disease Progression Neoplasm Recurrence, Local Kidney Failure, Chronic Stroke Recurrence Prostatic Neoplasms Myocardial Infarction Coronary Disease Colorectal Neoplasms Lung Neoplasms Lymphatic Metastasis HIV Infections Heart Failure Neoplasms Adenocarcinoma Diabetes Mellitus, Type 2 Diabetes Mellitus Hypertension Hip Fractures Diabetes Complications Aortic Valve Prolapse Carcinoma, Squamous Cell Ovarian Neoplasms Dementia Endometrial Neoplasms Stomach Neoplasms Carcinoma, Hepatocellular Acidosis, Lactic Neoplasm Invasiveness Coronary Artery Disease Carcinoma, Non-Small-Cell Lung Kidney Neoplasms Death, Sudden, Cardiac Death Pancreatic Neoplasms Brain Neoplasms Neoplasm Metastasis Hidradenitis Carcinoma, Renal Cell Chronic Disease Obesity Genetic Predisposition to Disease Friedreich Ataxia Neoplasms, Second Primary Peripheral Arterial Disease Colonic Neoplasms Postoperative Complications Fractures, Bone Occupational Diseases Kidney Diseases Adenocarcinoma, Mucinous Carcinoma Neoplasms, Glandular and Epithelial Melanoma Osteoporotic Fractures Atrial Fibrillation Acquired Immunodeficiency Syndrome Supratentorial Neoplasms Skin Neoplasms Cerebrovascular Disorders Urinary Bladder Neoplasms Brain Ischemia Renal Insufficiency Heart Diseases

Chemicals and Drugs20

8,11,14-Eicosatrienoic Acid Tumor Markers, Biological Biological Markers Coffee Prostate-Specific Antigen Receptors, Estrogen Anti-HIV Agents Receptors, Progesterone beta Carotene Creatinine C-Reactive Protein Hydroxymethylglutaryl-CoA Reductase Inhibitors Vitamin D alpha-Tocopherol Antineoplastic Agents, Hormonal Aspirin Vitamins Androgen Antagonists Antineoplastic Agents Uric Acid

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Proportional Hazards Models Risk Factors Cohort Studies Follow-Up Studies Prospective Studies Prognosis Survival Analysis Kaplan-Meier Estimate Incidence Retrospective Studies Survival Rate Multivariate Analysis Risk Assessment Treatment Outcome Predictive Value of Tests Risk Cause of Death Neoplasm Staging Confidence Intervals Disease-Free Survival Longitudinal Studies Mortality Registries SEER Program Questionnaires Body Mass Index Chi-Square Distribution Odds Ratio Renal Dialysis Severity of Illness Index Epidemiologic Methods Hospitalization Regression Analysis Models, Statistical Combined Modality Therapy Antiretroviral Therapy, Highly Active Analysis of Variance CD4 Lymphocyte Count Propensity Score Chemotherapy, Adjuvant Case-Control Studies Probability Complement Fixation Tests Treatment Failure Prostatectomy Randomized Controlled Trials as Topic Biometry Prevalence Immunohistochemistry Multicenter Studies as Topic Health Surveys Diet Surveys Life Tables Neoplasm Grading Estrogen Replacement Therapy ROC Curve Glomerular Filtration Rate Data Interpretation, Statistical Antineoplastic Combined Chemotherapy Protocols Reproducibility of Results Radiotherapy, Adjuvant Blood Pressure Nomograms Obesity Biostatistics Double-Blind Method Peritoneal Dialysis Kidney Transplantation Morbidity Karnofsky Performance Status Viral Load Reoperation Patient Selection Medical Record Linkage Linear Models Likelihood Functions Stroke Volume Amputation Patient Readmission Endpoint Determination Statistics, Nonparametric Actuarial Analysis Electrocardiography

Psychiatry and Psychology5

Smoking Alcohol Drinking Food Habits Life Style Dementia

Phenomena and Processes25

Time Factors Risk Body Mass Index Chi-Square Distribution Odds Ratio Postmenopause Diet CD4 Lymphocyte Count Probability Aging Glomerular Filtration Rate Polymorphism, Single Nucleotide Blood Pressure Menopause Nomograms Obesity Pregnancy Genetic Predisposition to Disease Graft Survival Viral Load Stroke Volume Polymorphism, Genetic Vascular Patency Algorithms Time

Disciplines and Occupations2

Immunohistochemistry Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena7

Age Distribution Sex Distribution Survival Socioeconomic Factors National Institutes of Health (U.S.)Forecasting Social Class

Technology, Industry, Agriculture7

Coffee Vegetables Fruit Dairy Products Dietary Supplements Meat Vitamins

Information Science16

Incidence Survival Rate Cause of Death Mortality Registries SEER Program Questionnaires Databases, Factual Computing Methodologies Prevalence Life Tables Data Interpretation, Statistical Morbidity Computer Simulation Medical Record Linkage Algorithms

Named Groups11

European Continental Ancestry Group African Americans African Continental Ancestry Group Veterans Survivors Ethnic Groups Asian Continental Ancestry Group Infant, Newborn Nurses Continental Population Groups Hispanic Americans

Health Care79

Proportional Hazards Models Risk Factors Cohort Studies Follow-Up Studies Prospective Studies Survival Analysis Kaplan-Meier Estimate Incidence Retrospective Studies Survival Rate Multivariate Analysis Risk Assessment Treatment Outcome Predictive Value of Tests Risk Cause of Death Age Factors Confidence Intervals Disease-Free Survival Longitudinal Studies Mortality Registries SEER Program Questionnaires Sex Factors Confounding Factors (Epidemiology)Comorbidity Body Mass Index Chi-Square Distribution Odds Ratio Severity of Illness Index Epidemiologic Methods Hospitalization Regression Analysis Age Distribution Models, Statistical Analysis of Variance Propensity Score Sex Distribution Case-Control Studies Probability Women's Health Socioeconomic Factors Treatment Failure Age of Onset Randomized Controlled Trials as Topic Residence Characteristics Biometry Prevalence Multicenter Studies as Topic Health Surveys Diet Surveys Life Tables ROC Curve Data Interpretation, Statistical Outcome Assessment (Health Care)Reproducibility of Results Medicare National Institutes of Health (U.S.)Ethnic Groups Nomograms Double-Blind Method Bias (Epidemiology)Educational Status Occupational Exposure Morbidity Karnofsky Performance Status Nurses Patient Selection Medical Record Linkage Linear Models Likelihood Functions Social Class Patient Readmission Statistics, Nonparametric Ancillary Services, Hospital Actuarial Analysis Healthy Worker Effect Healthcare Disparities

Geographicals25

Japan Taiwan Sweden Finland California Denmark China Netherlands Minnesota Europe Germany British Columbia Norway Hawaii Canada Korea Italy Massachusetts New England Chicago Western Australia Maryland Australia Washington Austria

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Proportional Hazards Models Risk Factors Cohort Studies Follow-Up Studies Prospective Studies Prognosis Survival Analysis Kaplan-Meier Estimate Incidence Retrospective Studies Survival Rate Multivariate Analysis Risk Assessment Time Factors Treatment Outcome Predictive Value of Tests 8,11,14-Eicosatrienoic Acid Risk Cause of Death Age Factors Neoplasm Staging Confidence Intervals Disease-Free Survival Longitudinal Studies Mortality Breast Neoplasms Cardiovascular Diseases Registries Japan SEER Program Smoking Questionnaires Sex Factors Disease Progression Neoplasm Recurrence, Local Confounding Factors (Epidemiology)Tumor Markers, Biological Kidney Failure, Chronic Stroke Comorbidity Recurrence Body Mass Index European Continental Ancestry Group Prostatic Neoplasms Chi-Square Distribution Odds Ratio Myocardial Infarction Renal Dialysis Taiwan Coronary Disease Biological Markers Severity of Illness Index Colorectal Neoplasms Lung Neoplasms Lymphatic Metastasis Epidemiologic Methods Postmenopause Diet HIV Infections Heart Failure Hospitalization Neoplasms African Americans Sweden Regression Analysis Adenocarcinoma Age Distribution Coffee Models, Statistical Alcohol Drinking Diabetes Mellitus, Type 2 Combined Modality Therapy Finland Antiretroviral Therapy, Highly Active Analysis of Variance CD4 Lymphocyte Count California Diabetes Mellitus Vegetables Propensity Score Chemotherapy, Adjuvant Databases, Factual Sex Distribution Case-Control Studies Computing Methodologies African Continental Ancestry Group Denmark Hypertension Survival Probability Women's Health Food Habits Prostate-Specific Antigen Life Style Hip Fractures Complement Fixation Tests Diabetes Complications Socioeconomic Factors Treatment Failure Age of Onset

No FAQ available that match "modeling proportional hazards models"